These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 627504)

  • 1. Potentiation of hypoxic pulmonary vasoconstriction by ethyl alcohol in dogs.
    Doekel RC; Weir EK; Looga R; Grover RF; Reeves JT
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Jan; 44(1):76-80. PubMed ID: 627504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of histamine antagonists to prevent hypoxic pulmonary vasoconstriction in dogs.
    Tucker A; Weir EK; Reeves JT; Grover RF
    J Appl Physiol; 1976 Apr; 40(4):496-500. PubMed ID: 6418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of leukotriene receptors and administration of a 5-lipoxygenase inhibitor do not affect hypoxic vasoconstriction.
    Thomas HM; Sourour MS; Lopez D; Foster SH
    Lung; 1989; 167(3):187-98. PubMed ID: 2567790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha adrenergic blockade and tissue catecholamine depletion on pulmonary vascular response to hypoxia.
    Silove ED; Grover RF
    J Clin Invest; 1968 Feb; 47(2):274-85. PubMed ID: 12066776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled nitric oxide partially reverses hypoxic pulmonary vasoconstriction in the dog.
    Romand JA; Pinsky MR; Firestone L; Zar HA; Lancaster JR
    J Appl Physiol (1985); 1994 Mar; 76(3):1350-5. PubMed ID: 8005882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin and prevention of hypoxic pulmonary vasoconstriction.
    Weir EK; Mlczoch J; Reeves JT; Grover RF
    J Lab Clin Med; 1976 Dec; 88(6):975-83. PubMed ID: 1033260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of pulmonary vasoconstrictor response with repeated intermittent hypoxia.
    Unger M; Atkins M; Briscoe WA; King TK
    J Appl Physiol Respir Environ Exerc Physiol; 1977 Oct; 43(4):662-7. PubMed ID: 908680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet antiserum inhibits hypoxic pulmonary vasoconstriction in the dog.
    Weir EK; Mlczoch J; Seavy J; Cohen JJ; Grover RF
    J Appl Physiol; 1976 Aug; 41(2):211-5. PubMed ID: 956104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute ingestion of ethanol on hemodynamics and hypoxic pulmonary vasoconstriction in dogs--role of leukotrienes.
    Lu CY; Wang DX; Yu SB
    J Tongji Med Univ; 1992; 12(4):253-6. PubMed ID: 1289577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine does not inhibit canine hypoxic pulmonary vasoconstriction.
    Bishop MJ; Kennard S; Artman LD; Cheney FW
    Am Rev Respir Dis; 1983 Dec; 128(6):998-1001. PubMed ID: 6650991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of minoxidil and nifedipine on hypoxic pulmonary vasoconstriction in dogs.
    Bishop MJ; Cheney FW
    J Cardiovasc Pharmacol; 1983; 5(2):184-9. PubMed ID: 6188887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.
    Höhne C; Drzimalla M; Krebs MO; Boemke W; Kaczmarczyk G
    J Physiol Pharmacol; 2003 Dec; 54(4):497-510. PubMed ID: 14726606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restored hypoxic pulmonary vasoconstriction by peripheral chemoreceptor agonists in dogs.
    Naeije R; Lejeune P; Vachiéry JL; Leeman M; Mélot C; Hallemans R; Delcroix M; Brimioulle S
    Am Rev Respir Dis; 1990 Oct; 142(4):789-95. PubMed ID: 2121078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of hypoxic pulmonary vasoconstriction in sheep. Role of prostaglandins.
    Ahmed T; Oliver W; Wanner A
    Am Rev Respir Dis; 1983 Jan; 127(1):59-62. PubMed ID: 6849552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone: effects on hypoxic pulmonary vasoconstriction.
    Bar-Or D; Good JT; Marx JA; Moore EE; Winkler JV
    Ann Emerg Med; 1984 Jul; 13(7):495-8. PubMed ID: 6331231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular effects of endotoxin in leukopenic dogs.
    Mlczoch J; Weir EK; Grover RF; Reeves JT
    Am Rev Respir Dis; 1978 Dec; 118(6):1097-9. PubMed ID: 369413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased left atrial pressure inhibits hypoxic pulmonary vasoconstriction.
    De Cannière D; Stefanidis C; Hallemans R; Delcroix M; Lejeune P; Naeije R
    J Appl Physiol (1985); 1994 Apr; 76(4):1502-6. PubMed ID: 8045825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of eicosanoid synthesis inhibitors on normoxic and hypoxic pulmonary vascular tone in dogs.
    Rubin LJ; Hughes JD; Lazar JD
    Am Rev Respir Dis; 1985 Jul; 132(1):93-8. PubMed ID: 3925829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strength of hypoxic vasoconstriction determines shunt fraction in dogs with atelectasis.
    Thomas HM; Garrett RC
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Jul; 53(1):44-51. PubMed ID: 6889592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytochrome P-450 in alveolar hypoxic pulmonary vasoconstriction in dogs.
    Miller MA; Hales CA
    J Clin Invest; 1979 Aug; 64(2):666-73. PubMed ID: 457876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.